Publications
- LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy2022 | Second Faculty of Medicine
- Thapsigargin-stimulated lad2 human mast cell line is a potent cellular adjuvant for the maturation of monocyte-derived dendritic cells for adoptive cellular immunotherapy2021 | Second Faculty of Medicine
- SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors2021 | Second Faculty of Medicine
- Simultaneous in vitro generation of human CD34+-derived dendritic cells and mast cells from non-mobilized peripheral blood mononuclear cells2018 | Second Faculty of Medicine
- Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients2017 | Second Faculty of Medicine
- Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma2024 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy2023 | Faculty of Science, First Faculty of Medicine, Second Faculty of Medicine
- Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors2022 | Second Faculty of Medicine, Central Library of Charles University
- Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy2022 | Second Faculty of Medicine
- The Role of miR-155 in Antitumor Immunity2022 | Second Faculty of Medicine
Loading network view...